Terms: = Breast cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Prognosis
396 results:
1. Chemotherapy is of prognostic significance to metaplastic breast cancer.
Zhang M; Yuan J; Wang M; Zhang M; Chen H
Sci Rep; 2024 Jan; 14(1):1210. PubMed ID: 38216630
[TBL] [Abstract] [Full Text] [Related]
2. TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2
Shao X; Yang D; Shan L; Yan X; Xu D; Li L; Sun Y; Yu Q; Zhou H; Ding Y; Tang J
Arch Toxicol; 2024 Mar; 98(3):865-881. PubMed ID: 38212449
[TBL] [Abstract] [Full Text] [Related]
3. Impact of immunohistochemical expression of kinesin family member 18A (Kif18A) and β-catenin in infiltrating breast carcinoma of no special type.
Hemida AS; Shabaan MI; Taha MA; Abdou AG
World J Surg Oncol; 2024 Jan; 22(1):15. PubMed ID: 38195458
[TBL] [Abstract] [Full Text] [Related]
4. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
5. Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer.
Ismail Y; Zakaria AS; Allam R; Götte M; Ibrahim SA; Hassan H
Pathol Res Pract; 2024 Jan; 253():154994. PubMed ID: 38071886
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Yang X; Tang T; Zhou T
World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
[TBL] [Abstract] [Full Text] [Related]
7. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA CARMN suppresses EMT through inhibiting transcription of MMP2 activated by DHX9 in breast cancer.
Liao H; Wang H; Zheng R; Yu Y; Zhang Y; Lv L; Zhang B; Chen J
Cell Signal; 2024 Jan; 113():110943. PubMed ID: 37890687
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma.
Yu Q; Wan D; Fu R; Li F; Zhang Y
Sci Rep; 2023 Oct; 13(1):17346. PubMed ID: 37833434
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and Imaging Features of MRI Screen-Detected breast cancer.
Ghuman N; Ambinder EB; Oluyemi ET; Sutton E; Myers KS
Clin Breast Cancer; 2024 Jan; 24(1):45-52. PubMed ID: 37821332
[TBL] [Abstract] [Full Text] [Related]
11. Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type.
Sijnesael T; Richard F; Rätze MA; Koorman T; Bassey-Archibong B; Rohof C; Daniel J; Desmedt C; Derksen PW
J Pathol; 2023 Dec; 261(4):477-489. PubMed ID: 37737015
[TBL] [Abstract] [Full Text] [Related]
12. Metaplastic breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
McMurtry V; Cleary AS; Ruano AL; Lomo L; Gulbahce HE
Am J Clin Oncol; 2023 Dec; 46(12):559-566. PubMed ID: 37705411
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Features and Prognoses of Patients With breast cancer Who Underwent Surgery.
Liu G; Kong X; Dai Q; Cheng H; Wang J; Gao J; Wang Y
JAMA Netw Open; 2023 Aug; 6(8):e2331078. PubMed ID: 37624596
[TBL] [Abstract] [Full Text] [Related]
14. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
[TBL] [Abstract] [Full Text] [Related]
15. Survival Benefit of Adjuvant Chemotherapy in Node-Positive breast cancer With a 21-Gene Recurrence Score of 14 to 25: A Real-World Study Based on the Inverse Probability of Treatment Weighting Method.
Ding W; Ye D; Zhu H; Lin Y; Li Z; Ruan G
Clin Breast Cancer; 2023 Oct; 23(7):e441-e450. PubMed ID: 37500355
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National cancer Database-breast cancer Registry.
Adachi Y; Asaga S; Kumamaru H; Kinugawa N; Sagara Y; Niikura N; Jinno H; Saji S; Toi M
Breast Cancer Res Treat; 2023 Oct; 201(3):397-408. PubMed ID: 37479943
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ.
Liu Y; Yu T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11181-11191. PubMed ID: 37354223
[TBL] [Abstract] [Full Text] [Related]
18. Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the breast and Predicts a Poor prognosis.
Wu K; Li W; Liu H; Niu C; Shi Q; Zhang J; Gao G; Sun H; Liu F; Fu L
Am J Pathol; 2023 Sep; 193(9):1267-1283. PubMed ID: 37301537
[TBL] [Abstract] [Full Text] [Related]
19. Surgery on Metastatic Foci is a Better Strategy for Stage IV breast cancer Patients with only Nonregional Lymph Node Metastasis.
Jiao Y; Guo X; Wu H; Lv Q
Adv Ther; 2023 Jul; 40(7):3247-3262. PubMed ID: 37270436
[TBL] [Abstract] [Full Text] [Related]
20. Histopathological growth patterns of neuroendocrine tumor liver metastases.
Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
[TBL] [Abstract] [Full Text] [Related]
[Next]
